Market Overview:

Bioactive peptides are fragments of proteins derived from food sources with physiological functional activities beyond their normal nutritional effects. Examples of bioactive peptides includes casokinins which are derived from milk protein as functional food ingredients and may have opioid-like effect. Bioactive peptides have wide range of use cases in functional foods and nutraceuticals due to their physiological functions like antioxidant, antihypertensive, immunomodulatory, antimicrobial etc.

Market Dynamics:

Rising health consciousness among consumers regarding consumption of healthy food products is a key driver for bioactive peptide market growth. Growing demand for clean label and natural ingredients in functional foods and nutraceuticals is also propelling the market demand. Bioactive peptides offer wide benefits in various disease management which would further augment their demand. However, high research and development costs involved in developing specific bioactive peptides can be a growth barrier over the forecast period. Stringent regulatory process is also a challenge for market participants.

Strength:
- The adoption of bioactive peptides as functional ingredients in dietary supplements and functional foods is increasing due to the associated health benefits such as improved cardiovascular health, balanced blood pressure, and digestive health.
- Rising consumption and production of probiotic foods and beverages provides opportunities for bioactive peptide market to grow.
- Ease of availability of raw materials utilized for manufacturing bioactive peptides such as dairy proteins facilitates the production process.

Weakness:
- High research and development cost involved in the production of bioactive peptides acts as a restraint.
- Limited product applications of bioactive peptides hampers the market growth.

Opportunity:
- Growing demand for preventive healthcare and natural remedies is expected to offer prospective opportunities for bioactive peptide manufacturers.
- Technological advancements in extraction processes to obtain peptides from new sources can augment the market expansion.

Threats:
- Stringent regulations pertaining to the approval of new bioactive ingredients may negatively impact the market revenue.
- Fluctuations in the prices of raw materials can pose challenges for industry players.

The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Key Takeaways
The global bioactive peptide market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing demand for functional foods and dietary supplements.

Regional analysis
North America dominates the global bioactive peptide market and is expected to continue its dominance over the forecast period. This is attributed to increasing health consciousness among consumers and growing inclination towards preventive healthcare in the region. Asia Pacific region is expected to be the fastest growing market for bioactive peptides owing to rising disposable income, growing population, and increasing awareness about health benefits of bioactive peptides.

Key players
Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.

Read More: https://businessinmyarea.com/medicine/the-bioactive-peptide-market-is-estimated-to-witness-high-growth-owing-to-functionality-trends